Last reviewed · How we verify
Botulinum toxin A 10U
At a glance
| Generic name | Botulinum toxin A 10U |
|---|---|
| Sponsor | YangHui |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Comparison of Dry Needling and Two Botulinum Toxins for Bruxism (NA)
- Botulinumtoxin A as a Treatment for Myalgia and Myofacial Pain in Patient With Temporomandibulardisorders (PHASE3)
- Treatment of Facial Flushing With Botulinum Toxin A Injections (PHASE4)
- Open Label, 6-month Study for High Frequency and Chronic Migraine,
- Incobotulinum Toxin A (Xeomin®) As A Treatment For Focal Task-Specific Dystonia Of The Musician's Hand (PHASE2)
- Higher Doses of Botulinum Toxin in the Treatment of Gummy Smile (PHASE1, PHASE2)
- Effects of Dose and Injection Site for Gummy Smile Treatment With Botulinum Type A (PHASE4)
- Clinical Trial to Evaluate the Efficacy and Safety of MBA-P01 in Treatment of Glabellar Lines (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Botulinum toxin A 10U CI brief — competitive landscape report
- Botulinum toxin A 10U updates RSS · CI watch RSS
- YangHui portfolio CI